164 related articles for article (PubMed ID: 31075287)
1. Special issue editorial: Recent progress of MicroRNA research in immunity.
Jiang S
Cancer Lett; 2019 Aug; 456():88-89. PubMed ID: 31075287
[No Abstract] [Full Text] [Related]
2. Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.
Fanini F; Fabbri M
Semin Cell Dev Biol; 2017 Jul; 67():23-28. PubMed ID: 27956165
[TBL] [Abstract][Full Text] [Related]
3. Introduction to the Special Issue: The tumor microenvironment and molecular regulation of innate immune cells.
Nicholson SE; Watowich SS
Mol Immunol; 2019 Jun; 110():1-2. PubMed ID: 30318379
[No Abstract] [Full Text] [Related]
4. MicroRNAs in type 2 immunity.
Johansson K; Weidner J; Rådinger M
Cancer Lett; 2018 Jul; 425():116-124. PubMed ID: 29604393
[TBL] [Abstract][Full Text] [Related]
5. Signaling by exosomal microRNAs in cancer.
Falcone G; Felsani A; D'Agnano I
J Exp Clin Cancer Res; 2015 Apr; 34(1):32. PubMed ID: 25886763
[TBL] [Abstract][Full Text] [Related]
6. Noncoding RNAs in Cancer Immunology.
Li Q; Liu Q
Adv Exp Med Biol; 2016; 927():243-64. PubMed ID: 27376738
[TBL] [Abstract][Full Text] [Related]
7. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.
Rupaimoole R; Calin GA; Lopez-Berestein G; Sood AK
Cancer Discov; 2016 Mar; 6(3):235-46. PubMed ID: 26865249
[TBL] [Abstract][Full Text] [Related]
8. Regulation of tumor angiogenesis by microRNAs: State of the art.
Goradel NH; Mohammadi N; Haghi-Aminjan H; Farhood B; Negahdari B; Sahebkar A
J Cell Physiol; 2019 Feb; 234(2):1099-1110. PubMed ID: 30070704
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs Reprogram Tumor Immune Response.
Cao W; Cheng W; Wu W
Methods Mol Biol; 2018; 1699():67-74. PubMed ID: 29086368
[TBL] [Abstract][Full Text] [Related]
10. miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells function.
Noman MZ; Janji B; Berchem G; Chouaib S
Cancer Lett; 2016 Sep; 380(1):257-62. PubMed ID: 26523672
[TBL] [Abstract][Full Text] [Related]
11. Let's fight cancer: let-7 is a tool to enhance antitumor immune responses.
Pobezinsky LA; Wells AC
Future Oncol; 2018 May; 14(12):1141-1145. PubMed ID: 29683340
[No Abstract] [Full Text] [Related]
12. Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumors.
Seliger B
Cytokine Growth Factor Rev; 2017 Aug; 36():49-56. PubMed ID: 28739030
[TBL] [Abstract][Full Text] [Related]
13. Suggested roles for microRNA in tumors.
Perge P; Nagy Z; Igaz I; Igaz P
Biomol Concepts; 2015 Apr; 6(2):149-55. PubMed ID: 25870972
[TBL] [Abstract][Full Text] [Related]
14. Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics.
Smolle MA; Calin HN; Pichler M; Calin GA
FEBS J; 2017 Jul; 284(13):1952-1966. PubMed ID: 28132417
[TBL] [Abstract][Full Text] [Related]
15. [MicroRNA and cancer].
Kiselev FL
Mol Biol (Mosk); 2014; 48(2):232-42. PubMed ID: 25850292
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathways: microRNAs, cancer cells, and microenvironment.
Berindan-Neagoe I; Calin GA
Clin Cancer Res; 2014 Dec; 20(24):6247-53. PubMed ID: 25512634
[TBL] [Abstract][Full Text] [Related]
17. The microRNA pathway and cancer.
Kwak PB; Iwasaki S; Tomari Y
Cancer Sci; 2010 Nov; 101(11):2309-15. PubMed ID: 20726859
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment.
Penfornis P; Vallabhaneni KC; Whitt J; Pochampally R
Int J Cancer; 2016 Jan; 138(1):14-21. PubMed ID: 25559768
[TBL] [Abstract][Full Text] [Related]
19. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance.
Harrandah AM; Mora RA; Chan EKL
Cancer Lett; 2018 Dec; 438():126-132. PubMed ID: 30237038
[TBL] [Abstract][Full Text] [Related]
20. Friend or Foe: MicroRNAs in the p53 network.
Luo Z; Cui R; Tili E; Croce C
Cancer Lett; 2018 Apr; 419():96-102. PubMed ID: 29330109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
